Pathos News and Activities

Pathos is one of the...

• TOB Iconic 10,000;
• Unicorn.

Acquisition, funding and merger involving Pathos.

• Pathos becomes a unicorn with its fundraising of $365 Million. (posted on July 4 2025).

View the org chart displaying its 16 main executives

Most searched biographies at Pathos

• Iker Huerga, Chief Executive Officer
• Amit Mehta, Director
• Ryan Fukushima, Director

Popular executive movements at Pathos

• Sumit Kumar has joined the company as Vice President and Head, Chemistry, Manufacturing, Controls and Technical Operations  (posted on September 29 2025).

Create your alert
to follow the executive moves at Pathos.

Pathos has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Pathos

Social media about Pathos

• Pathos on Wikipedia, Google News & Yahoo Finance
• Pathos on LinkedIn, X (Twitter) & YouTube